Literature DB >> 7897112

Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease.

W Palmas1, J D Friedman, G A Diamond, H Silber, H Kiat, D S Berman.   

Abstract

OBJECTIVES: This study assessed the incremental value of technetium-99m myocardial single-photon emission computed tomography (SPECT) and simultaneous first-pass radionuclide angiography, when added to treadmill exercise, for prediction of the extent of coronary artery disease.
BACKGROUND: Technetium-99m count statistics permit the simultaneous assessment of myocardial perfusion and function. However, whether this characteristic improves prediction of the extent of coronary artery disease remains unknown.
METHODS: We studied 70 consecutive patients who had coronary angiography within 6 months of the scintigraphic study. All patients underwent a symptom-limited treadmill exercise test. Treadmill data were summarized using a previously validated score. Left ventricular ejection fraction and regional wall motion were evaluated from a first-pass radionuclide angiogram acquired at peak treadmill exercise in the anterior view. Perfusion was assessed visually. Extent of angiographic disease was expressed as the presence or absence of multivessel disease (more than two coronary artery territories with > 50% stenosis) and as a score that reflects the location of severe (> 75%) stenosis.
RESULTS: Stepwise addition of scintigraphic data (perfusion first, followed by function) to the treadmill score showed significant incremental value for prediction of the angiographic score at each step; exercise ejection fraction alone was the strongest independent predictor. Discriminant accuracy for detection of multivessel disease was also improved by the addition of perfusion information to the treadmill score and addition of regional wall motion analysis to both of them. In this case, ejection fraction failed to show independent value.
CONCLUSIONS: The addition of simultaneously performed sestamibi perfusion SPECT and first-pass radionuclide angiography to the treadmill exercise test significantly improved prediction of the extent of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7897112     DOI: 10.1016/0735-1097(94)00523-s

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Does exercise radionuclide angiography still have a role in clinical cardiac assessment?

Authors:  A D Kelion; A P Banning; O J Ormerod
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

2.  Anatomy of a meta-analysis: a critical review of "exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance".

Authors:  S M Kymes; D E Bruns; L J Shaw; K N Gillespie; J W Fletcher
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

3.  Quantitative gated single photon emission computed tomography imaging: a counts-based method for display and measurement of regional and global ventricular systolic function.

Authors:  W H Smith; R J Kastner; D A Calnon; D Segalla; G A Beller; D D Watson
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

4.  Comparison of technetium-99m sestamibi left ventricular wall motion and perfusion studies with thallium-201 perfusion imaging: in search of the combination of variables with the highest accuracy in predicting coronary artery disease.

Authors:  J F Verzijlbergen; A H Zwinderman; C A Ascoop; E E van der Wall; M G Niemeyer; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1996-05

5.  Simultaneous perfusion/function imaging.

Authors:  D S Berman; G Germano; H Kiat; J Friedman
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

6.  Repeatability of treadmill exercise ejection fraction and wall motion using technetium 99m-labeled sestamibi first-pass radionuclide ventriculography.

Authors:  B Benari; H Kiat; J Erel; M Hyun; F P Wang; C Williams; J D Friedman; G Germano; K F Van Train; D Berman
Journal:  J Nucl Cardiol       Date:  1995 Nov-Dec       Impact factor: 5.952

7.  Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology.

Authors:  E G DePuey; S Port; F J Wackers; A Rozanski; E H Botvinick; M W Dae; N Tamaki
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

Review 8.  Assessment of myocardial perfusion by magnetic resonance imaging.

Authors:  J Crnac; M C Schmidt; P Theissen; U Sechtem
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

Review 9.  Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?

Authors:  B Caner; G A Beller
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

10.  Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.